Myndlift Healthcare Secures RMB 100 Million in Series B Funding to Propel Innovation and Market Reach of Brain-Computer Interface Rehabilitation Solutions
2 day ago / Read about 0 minute
Author:小编   

Zhejiang Myndlift Healthcare Technology Co., Ltd. has recently proudly declared the successful closure of its Series B funding round, amassing an impressive RMB 100 million. This round saw participation from esteemed investors such as GSR United Capital and Shanghai Chuangda Industrial High-tech Group Co., Ltd. The influx of capital is earmarked to fuel advancements in the realm of brain-computer interface rehabilitation, expediting product enhancements, broadening market penetration, and advancing the technological industrialization journey. Since its inception in 2018, Myndlift Healthcare has been at the forefront of pioneering research and development in intelligent human-machine integration brain-computer interface technology, with a steadfast dedication to its practical application and transformation within the rehabilitation medicine sector.